keyword
https://read.qxmd.com/read/38652701/raas-in-diabetic-retinopathy-mechanisms-and-therapies
#1
REVIEW
Xin Li, Yu-Hong Fu, Xue-Wei Tong, Yi-Tong Zhang, Yong-Yan Shan, Yu-Xin Xu, Sheng-Dan Pu, Xin-Yuan Gao
Diabetic retinopathy (DR) is a complication of diabetes with a complex pathophysiology and multiple factors involved. Recently, it has been found that the upregulation of the renin-angiotensin-aldosterone system (RAAS) leads to overexpression of angiotensin II (Ang II), which induces oxidative stress, inflammation, and angiogenesis in the retina. Therefore, RAAS may be a promising therapeutic target in DR. Notably, RAAS inhibitors are often used in the treatment of hypertension. Still, the potential role and mechanism of DR must be further studied...
April 19, 2024: Archives of Endocrinology and Metabolism
https://read.qxmd.com/read/38652538/hepatic-hif2-is-a-key-determinant-of-manganese-excess-and-polycythemia-in-slc30a10-deficiency
#2
JOURNAL ARTICLE
Milankumar Prajapati, Jared Z Zhang, Lauren Chiu, Grace S Chong, Courtney J Mercadante, Heather L Kowalski, Bradley S Delaney, Jessica A Anderson, Shuling Guo, Mariam Aghajan, Thomas B Bartnikas
Manganese is an essential yet potentially toxic metal. Initially reported in 2012, mutations in SLC30A10 are the first known inherited cause of manganese excess. SLC30A10 is an apical membrane protein that exports manganese from hepatocytes into bile and from enterocytes into the lumen of the gastrointestinal tract. SLC30A10 deficiency results in impaired gastrointestinal manganese excretion, leading to manganese excess, neurologic deficits, liver cirrhosis, polycythemia, and erythropoietin excess. Neurologic and liver disease are attributed to manganese toxicity...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652489/synergistically-engineered-nanotransethosomes-for-co-delivery-of-methotrexate-and-baicalin-for-enhanced-transdermal-delivery-against-rheumatoid-arthritis-formulation-characterization-and-invivo-pharmacodynamic-evaluation
#3
JOURNAL ARTICLE
Syeda Nashvia Adin, Isha Gupta, Mohd Aqil, Mohd Mujeeb, Abul Kalam Najmi
Rheumatoid arthritis (RA) is a systemic autoimmune disease that significantly impacts the quality of life of those affected. Owing to the complex pathophysiology of RA, it is not possible for any singular treatment to entirely impede the progression of the disease. Hence, the current study aimed to adopt a holistic and synergistic approach towards the management of RA by means of a co-delivery strategy involving methotrexate (MTH), a conventional slow-acting anti-rheumatic drug, and baicalin (BCN), a bioactive phytochemical using a transethosomal (TRS) gel formulation...
April 23, 2024: Journal of Drug Targeting
https://read.qxmd.com/read/38652420/proteomics-in-patients-with-fibromyalgia-syndrome-a-systematic-review-of-observational-studies
#4
REVIEW
Arriana Gkouvi, Sotirios G Tsiogkas, Dimitrios P Bogdanos, Helen Gika, Dimitrios G Goulis, Maria G Grammatikopoulou
PURPOSE OF REVIEW: Fibromyalgia syndrome (FMS) is a disease of unknown pathophysiology, with the diagnosis being based on a set of clinical criteria. Proteomic analysis can provide significant biological information for the pathophysiology of the disease but may also reveal biomarkers for diagnosis or therapeutic targets. The present systematic review aims to synthesize the evidence regarding the proteome of adult patients with FMS using data from observational studies. RECENT FINDINGS: An extensive literature search was conducted in MEDLINE/PubMed, CENTRAL, and clinicaltrials...
April 23, 2024: Current Pain and Headache Reports
https://read.qxmd.com/read/38652370/expression-patterns-of-mirnas-in-egyptian-children-with-adhd-clinical-study-with-correlation-analysis
#5
JOURNAL ARTICLE
Hala M Zeidan, Neveen Hassan Nashaat, Maha Hemimi, Adel F Hashish, Amal Elsaeid, Nagwa Abd El-Ghaffar, Suzette I Helal, Nagwa A Meguid
ADHD has huge knowledge gaps concerning its etiology. MicroRNAs (miRNAs) provide promising diagnostic biomarkers of human pathophysiology and may be a novel therapeutic option. The aim was to investigate the levels of miR-34c-3p, miR-155, miR-138-1, miR-296-5p, and plasma brain-derived neurotrophic factor (BDNF) in a group of children with ADHD compared to neurotypicals and to explore correlations between these measures and some clinical data. The participants were children with ADHD in Group I (N = 41; age: 8...
April 23, 2024: Journal of Molecular Neuroscience: MN
https://read.qxmd.com/read/38652364/role-of-the-raas-in-mediating-the-pathophysiology-of-covid-19
#6
REVIEW
Jakub Jasiczek, Adrian Doroszko, Tymoteusz Trocha, Małgorzata Trocha
The renin-angiotensin-aldosterone system (RAAS) holds a position of paramount importance as enzymatic and endocrine homeostatic regulator concerning the water-electrolyte and acid-base balance. Nevertheless, its intricacy is influenced by the presence of various complementary angiotensins and their specific receptors, thereby modifying the primary RAAS actions. Angiotensin-converting enzyme 2 (ACE2) acts as a surface receptor for SARS-CoV-2, establishing an essential connection between RAAS and COVID-19 infection...
April 23, 2024: Pharmacological Reports: PR
https://read.qxmd.com/read/38652355/recent-united-states-developments-in-the-pharmacological-treatment-of-dry-eye-disease
#7
REVIEW
David Valdés-Arias, Elyana V T Locatelli, Paula A Sepulveda-Beltran, Simran Mangwani-Mordani, Juan Carlos Navia, Anat Galor
Dry eye disease (DED) can arise from a variety of factors, including inflammation, meibomian gland dysfunction (MGD), and neurosensory abnormalities. Individuals with DED may exhibit a range of clinical signs, including tear instability, reduced tear production, and epithelial disruption, that are driven by different pathophysiological contributors. Those affected often report a spectrum of pain and visual symptoms that can impact physical and mental aspects of health, placing an overall burden on an individual's well-being...
April 23, 2024: Drugs
https://read.qxmd.com/read/38652263/treatment-of-transthyretin-cardiac-amyloidosis
#8
JOURNAL ARTICLE
Dimitrios Bampatsias, Abdirahman Wardhere, Mathew S Maurer
PURPOSE OF REVIEW: Tafamidis is currently the only approved disease-modifying treatment for ATTR-CM. However, there have been important developments in the treatment of ATTR-CM, as the results of two phase 3 trials were published and several other trials are in their final stages. In this review, we summarize current and future therapies for ATTR-CM. RECENT FINDINGS: Recently, acoramidis, a TTR stabilizer has been proven to be effective in reducing mortality and morbidity compared to placebo in the ATTRibute-CM trial...
April 22, 2024: Current Opinion in Cardiology
https://read.qxmd.com/read/38652234/haptoglobin-attenuates-cerebrospinal-fluid-hemoglobin-induced-neurological-deterioration-in-sheep
#9
JOURNAL ARTICLE
Bart R Thomson, Nina Schwendinger, Katrin Beckmann, Thomas Gentinetta, Daniel Couto, Sandra Wymann, Valérie Verdon, Raphael M Buzzi, Kevin Akeret, Peter W Kronen, Eva M Weinberger, Ulrike Held, Frauke Seehusen, Henning Richter, Dominik J Schaer, Michael Hugelshofer
Secondary brain injury (SBI) occurs with a lag of several days post-bleeding in patients with aneurysmal subarachnoid hemorrhage (aSAH) and is a strong contributor to mortality and long-term morbidity. aSAH-SBI coincides with cell-free hemoglobin (Hb) release into the cerebrospinal fluid. This temporal association and convincing pathophysiological concepts suggest that CSF-Hb could be a targetable trigger of SBI. However, sparse experimental evidence for Hb's neurotoxicity in vivo defines a significant research gap for clinical translation...
April 23, 2024: Translational Stroke Research
https://read.qxmd.com/read/38652110/proteomic-studies-in-vwa1-related-neuromyopathy-allowed-new-pathophysiological-insights-and-the-definition-of-blood-biomarkers
#10
JOURNAL ARTICLE
Mohammed Athamneh, Nassam Daya, Andreas Hentschel, Andrea Gangfuss, Tobias Ruck, Adela Della Marina, Ulrike Schara-Schmidt, Albert Sickmann, Anne-Katrin Güttsches, Marcus Deschauer, Corinna Preusse, Matthias Vorgerd, Andreas Roos
Bi-allelic variants in VWA1, encoding Von Willebrand Factor A domain containing 1 protein localized to the extracellular matrix (ECM), were linked to a neuromuscular disorder with manifestation in child- or adulthood. Clinical findings indicate a neuromyopathy presenting with muscle weakness. Given that pathophysiological processes are still incompletely understood, and biomarkers are still missing, we aimed to identify blood biomarkers of pathophysiological relevance: white blood cells (WBC) and plasma derived from six VWA1-patients were investigated by proteomics...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38652067/machine-learning-based-perivascular-space-volumetry-in-alzheimer-disease
#11
JOURNAL ARTICLE
Katerina Deike, Andreas Decker, Paul Scheyhing, Julia Harten, Nadine Zimmermann, Daniel Paech, Oliver Peters, Silka D Freiesleben, Luisa-Sophie Schneider, Lukas Preis, Josef Priller, Eike Spruth, Slawek Altenstein, Andrea Lohse, Klaus Fliessbach, Okka Kimmich, Jens Wiltfang, Claudia Bartels, Niels Hansen, Frank Jessen, Ayda Rostamzadeh, Emrah Düzel, Wenzel Glanz, Enise I Incesoy, Michaela Butryn, Katharina Buerger, Daniel Janowitz, Michael Ewers, Robert Perneczky, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H Munk, Annika Spottke, Nina Roy, Michael Wagner, Sandra Roeske, Michael T Heneka, Frederic Brosseron, Alfredo Ramirez, Laura Dobisch, Steffen Wolfsgruber, Luca Kleineidam, Renat Yakupov, Melina Stark, Matthias C Schmid, Moritz Berger, Stefan Hetzer, Peter Dechent, Klaus Scheffler, Gabor C Petzold, Anja Schneider, Alexander Effland, Alexander Radbruch
OBJECTIVES: Impaired perivascular clearance has been suggested as a contributing factor to the pathogenesis of Alzheimer disease (AD). However, it remains unresolved when the anatomy of the perivascular space (PVS) is altered during AD progression. Therefore, this study investigates the association between PVS volume and AD progression in cognitively unimpaired (CU) individuals, both with and without subjective cognitive decline (SCD), and in those clinically diagnosed with mild cognitive impairment (MCI) or mild AD...
April 23, 2024: Investigative Radiology
https://read.qxmd.com/read/38652065/astrocytes-at-the-intersection-of-ageing-obesity-and-neurodegeneration
#12
REVIEW
Wyn Firth, Katherine R Pye, Paul G Weightman Potter
Once considered passive cells of the central nervous system (CNS), glia are now known to actively maintain the CNS parenchyma; in recent years, the evidence for glial functions in CNS physiology and pathophysiology has only grown. Astrocytes, a heterogeneous group of glial cells, play key roles in regulating the metabolic and inflammatory landscape of the CNS and have emerged as potential therapeutic targets for a variety of disorders. This review will outline astrocyte functions in the CNS in healthy ageing, obesity, and neurodegeneration, with a focus on the inflammatory responses and mitochondrial function, and will address therapeutic outlooks...
April 24, 2024: Clinical Science (1979-)
https://read.qxmd.com/read/38652044/retrospective-study-of-540-cats-with-respiratory-diseases-in-japan-2003-2020
#13
JOURNAL ARTICLE
Aki Fujiwara-Igarashi, Takafumi Ohshima, Ryusei Kojima, Michio Fujita, Yuta Nakazawa
BACKGROUND: Few epidemiological studies on respiratory medicine and the relationship between clinical signs and various respiratory diseases in cats have been reported. OBJECTIVES: This retrospective study aimed to investigate the prevalence and breed predisposition to feline respiratory diseases in Japan and determine the association between clinical signs, duration and type of respiratory diseases. METHODS: The medical records of cats with feline respiratory diseases were examined to obtain information on age, sex, breed, final diagnosis, clinical signs and duration...
May 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38651925/integrating-genetic-and-immune-factors-to-uncover-pathogenetic-mechanisms-of-viral-associated-pulmonary-aspergillosis
#14
REVIEW
Samuel M Gonçalves, Inês Pereira, Simon Feys, Cristina Cunha, Georgios Chamilos, Martin Hoenigl, Joost Wauters, Frank L van de Veerdonk, Agostinho Carvalho
Invasive pulmonary aspergillosis is a severe fungal infection primarily affecting immunocompromised patients. Individuals with severe viral infections have recently been identified as vulnerable to developing invasive fungal infections. Both influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) are linked to high mortality rates, emphasizing the urgent need for an improved understanding of disease pathogenesis to unveil new molecular targets with diagnostic and therapeutic potential...
April 23, 2024: MBio
https://read.qxmd.com/read/38651895/exosomal-malat1-from-macrophages-treated-with-high-levels-of-glucose-upregulates-lc3b-expression-via-mir-204-5p-downregulation
#15
JOURNAL ARTICLE
Shyu Kou-Gi, Bao-Wei Wang, Chun-Ming Pan, Wei-Jen Fang, Chiu-Mei Lin
BACKGROUND: Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) plays a critical role in the pathophysiology of diabetes-related complications. However, whether macrophage-derived MALAT1 affects autophagic activity under hyperglycemic conditions is unclear. Therefore, we investigated the molecular regulatory mechanisms of macrophage-derived MALAT1 and autophagy under hyperglycemic conditions. METHODS: Hyperglycemia was induced by culturing macrophages in 25 mM glucose for 1 h...
April 23, 2024: Journal of the Chinese Medical Association: JCMA
https://read.qxmd.com/read/38651796/persistent-cytopenia-after-cd19-car-t-therapy-in-relapsed-refractory-dlbcl-patients-could-be-a-predictor-of-efficacy-and-side-effects
#16
JOURNAL ARTICLE
Jingyi Li, Juan Mu, Jia Wang, Xin Li, Qing Li, Yili Jiang, Rui Cui, Qi Deng
Hematological toxicity is a severe adverse event (AE) in anti-CD19 chimeric antigen receptor (CAR) T cell therapy for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). However, the pathophysiological mechanism underlying prolonged cytopenia and the relationship between persistent cytopenia, efficacy, and AEs after anti-CD19 CAR T cell therapy are unknown. Therefore, this study explored whether persistent cytopenia after anti-CD19 CAR T cell therapy in patients with R/R DLBCL can predict therapeutic efficacy and AEs...
2024: Cell Transplantation
https://read.qxmd.com/read/38651743/predictors-of-irritable-bowel-syndrome-like-symptoms-in-quiescent-inflammatory-bowel-disease
#17
JOURNAL ARTICLE
Mehwish Ahmed, Autumn Pu, Kara Jencks, Shrinivas Bishu, Peter Higgins, William D Chey, Krishna Rao, Allen Lee
BACKGROUND: Many patients with quiescent inflammatory bowel disease (IBD) suffer from irritable bowel syndrome (IBS)-like symptoms. Although these symptoms cause significant reductions in quality of life, evidence-based treatments are lacking as risk factors and pathophysiology of these symptoms are not clearly defined. We aimed to identify risk factors for development of IBS-like symptoms in IBD patients with quiescent disease. METHODS: We performed a single-center retrospective cohort study of adults with IBD from 2015 to 2021...
April 23, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38651637/the-wolfram-like-variant-wfs1-e864k-destabilizes-mam-and-compromises-autophagy-and-mitophagy-in-human-and-mice
#18
JOURNAL ARTICLE
Simone Patergnani, Méghane S Bataillard, Alberto Danese, Stacy Alves, Chantal Cazevieille, René Valéro, Lisbeth Tranebjærg, Tangui Maurice, Paolo Pinton, Benjamin Delprat, Elodie M Richard
Dominant variants in WFS1 (wolframin ER transmembrane glycoprotein), the gene coding for a mitochondria-associated endoplasmic reticulum (ER) membrane (MAM) resident protein, have been associated with Wolfram-like syndrome (WLS). In vitro and in vivo , WFS1 loss results in reduced ER to mitochondria calcium (Ca2+ ) transfer, mitochondrial dysfunction, and enhanced macroautophagy/autophagy and mitophagy. However, in the WLS pathological context, whether the mutant protein triggers the same cellular processes is unknown...
April 23, 2024: Autophagy
https://read.qxmd.com/read/38651454/eculizumab-treatment-of-massive-hemolysis-occurring-in-a-rare-co-existence-of-paroxysmal-nocturnal-hemoglobinuria-and-myasthenia-gravis
#19
Ráhel Réka Bicskó, Árpád Illés, Zsuzsanna Hevessy, Gergely Ivády, György Kerekes, Gábor Méhes, Tünde Csépány, Lajos Gergely
The co-occurrence of myasthenia gravis (MG) and paroxysmal nocturnal hemoglobinuria (PNH) is rare; only one case has been published so far. We report a 63-year-old Caucasian female patient who was diagnosed with MG at the age of 43. Thymoma was also detected, and so it was surgically resected, which resulted in reasonable disease control for nearly 20 years. Slight hemolysis began to emerge, and then myasthenia symptoms progressed, so immunosuppressive therapy was started. Due to progressive disease and respiratory failure, the patient underwent plasmapheresis, and ventilatory support was stopped...
April 19, 2024: Hematology Reports
https://read.qxmd.com/read/38651450/pathophysiology-clinical-manifestations-and-diagnosis-of-immune-thrombocytopenia-contextualization-from-a-historical-perspective
#20
REVIEW
Daniel Martínez-Carballeira, Ángel Bernardo, Alberto Caro, Inmaculada Soto, Laura Gutiérrez
Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, affecting multiple components of the immune system and causing both peripheral destruction of platelets and impaired central megakaryopoiesis and platelet production in the bone marrow. Here, we intend to contextualize the current knowledge on the pathophysiology, terminology, epidemiology, clinical manifestations, diagnosis, and prognosis of ITP from a historical perspective and the first references to the never-stopping garnering of knowledge about this entity...
April 3, 2024: Hematology Reports
keyword
keyword
6683
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.